Can I read Interferon-induced Transmembrane Protein 3 in Hepatocellular Carcinoma Patients on EtoBox?

Interferon-induced Transmembrane Protein 3 in Hepatocellular Carcinoma Patients by Rania M. Bondok; Lamiaa A. Barakat; Alyaa R. Elsergany; Nancy Mahsoub; Maivel H. Ghattas is a Medicine article available to read on EtoBox.

What is Interferon-induced Transmembrane Protein 3 in Hepatocellular Carcinoma Patients about?

## Objective The study aimed to investigate the over expression of IFITM3 in hepatocellular carcinoma Egyptian patients. ## Background Hepatocellular carcinoma (HCC) continues to be a serious disease burden. Interferon Induced Transmembrane protein 3 (IFITM3) is a protein that encoded in humans by the IFITM3 gene. It plays a critical role in the immune system’s defense, responsible for a large portion of the antiviral activity. In this study, we showed that IFITM3 rs 12252-CC was over expressed in HCC patients compared to control group with HCV infection. ## Method DNA sequencing was applied for detection of IFITM3 rs 12252-CC and IFITM3 protein level was measured by ELISA to 50 patients with HCC with cirrhosis and 50 with Hepatitis C virus infection. ## Results The obtained results of this study indicated that IFITM3 rs 12252-CC was significantly elevated in HCC group, the codominant model of CC genotype of IFITM3 gene had high association with risk of hepatocellular carcinoma with odd ratio (OR) = 2.70, p = 0.041. ## Conclusion IFITM3 play an important role in progression of hepatocellular carcinoma. Results revealed that IFITM3 rs 12252-CC among Hepatocellular carcinoma patients

Who reads Interferon-induced Transmembrane Protein 3 in Hepatocellular Carcinoma Patients?

Author

Rania M. Bondok; Lamiaa A. Barakat; Alyaa R. Elsergany; Nancy Mahsoub; Maivel H. Ghattas

Publisher

Springer Science and Business Media LLC

Published

2023

Language

EN

Field

Medicine (Health Sciences)